Literature DB >> 9709721

Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease.

L Vernacchio1, E J Neufeld, K MacDonald, S Kurth, S Murakami, C Hohne, M King, D Molrine.   

Abstract

We compared the immunogenicity of 7-valent pneumococcal-conjugate vaccine plus 23-valent pneumococcal vaccine to immunization with 23-valent vaccine only in individuals > or = 2 years of age with sickle cell disease. IgG pneumococcal antibody concentrations were higher in the combined schedule group with no increase in side effects observed after immunization with 23-valent vaccine.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9709721     DOI： 10.1016/s0022-3476(98)70235-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  20 in total

Review 1.  New pneumococcal vaccines for children.

Authors:  S Choo; A Finn
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.

Authors:  R S Chu; T McCool; N S Greenspan; J R Schreiber; C V Harding
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 3.  Prevention and management of infection in children with sickle cell anaemia.

Authors:  W Y Wong
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Serum opsonic activity in infants with sickle-cell disease immunized with pneumococcal polysaccharide protein conjugate vaccine. The Pneumococcal Conjugate Vaccine Study Group.

Authors:  A Nowak-Wegrzyn; J A Winkelstein; A J Swift; H M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  2000-09

Review 5.  Advances in pneumococcal vaccines: advantages for infants and children.

Authors:  Jolanta Bernatoniene; Adam Finn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 6.  Is it worth investigating splenic function in patients with celiac disease?

Authors:  Antonio Di Sabatino; Laura Brunetti; Gabriella Carnevale Maffè; Paolo Giuffrida; Gino Roberto Corazza
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 7.  A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens.

Authors:  Calvin C Daniels; P David Rogers; Chasity M Shelton
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

8.  A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant.

Authors:  Kathryn Malone; Stephanie Clark; Jo Ann Palmer; Sonya Lopez; Madhura Pradhan; Susan Furth; Jason Kim; Brian Fisher; Benjamin Laskin
Journal:  Pediatr Transplant       Date:  2016-06-22

Review 9.  Should the new pneumococcal vaccine be used in high-risk children?

Authors:  A Finn; R Booy; R Moxon; M Sharland; P Heath
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

10.  Assessing the Immunogenic Response of a Single Center's Pneumococcal Vaccination Protocol in Sickle Cell Disease.

Authors:  Jonathan D Santoro; Leann Myers; Julie Kanter
Journal:  J Pediatr Hematol Oncol       Date:  2016-04       Impact factor: 1.289
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.